1. First-in-human safety and immunogenicity investigations of three adjuvanted reduced dose inactivated poliovirus vaccines (IPV-Al SSI) compared to full dose IPV Vaccine SSI when given as a booster vaccination to adolescents with a history of IPV vaccination at 3, 5, 12 months and 5 years of age. Issue 4 (23rd January 2017) Authors: Lindgren, Line M.; Tingskov, Pernille N.; Justesen, Annette H.; Nedergaard, Bettina S.; Olsen, Klaus J.; Andreasen, Lars V.; Kromann, Ingrid; Sørensen, Charlotte; Dietrich, Jes; Thierry-Carstensen, Birgit Journal: Vaccine Issue: Volume 35:Issue 4(2017) Page Start: 596 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A phase 1b randomized study of the safety and immunological responses to vaccination with H4:IC31, H56:IC31, and BCG revaccination in Mycobacterium tuberculosis-uninfected adolescents in Cape Town, South Africa. (April 2020) Authors: Bekker, Linda-Gail; Dintwe, One; Fiore-Gartland, Andrew; Middelkoop, Keren; Hutter, Julia; Williams, Anthony; Randhawa, April K.; Ruhwald, Morten; Kromann, Ingrid; Andersen, Peter L.; DiazGranados, Carlos A.; Rutkowski, Kathryn T.; Tait, Dereck; Miner, Maurine D.; Andersen-Nissen, Erica; De Rosa,... Journal: EClinicalMedicine Issue: Volume 21(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Safety and immunogenicity of the novel H4:IC31 tuberculosis vaccine candidate in BCG-vaccinated adults: Two phase I dose escalation trials. Issue 12 (14th March 2017) Authors: Norrby, Maria; Vesikari, Timo; Lindqvist, Lars; Maeurer, Markus; Ahmed, Raija; Mahdavifar, Shahnaz; Bennett, Sean; McClain, J. Bruce; Shepherd, Barbara M.; Li, Daner; Hokey, David A.; Kromann, Ingrid; Hoff, Søren T.; Andersen, Peter; de Visser, Adriëtte W.; Joosten, Simone A.; Ottenhoff, Tom H.M.... Journal: Vaccine Issue: Volume 35:Issue 12(2017) Page Start: 1652 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Immunogenicity and safety of three aluminium hydroxide adjuvanted vaccines with reduced doses of inactivated polio vaccine (IPV-Al) compared with standard IPV in young infants in the Dominican Republic: a phase 2, non-inferiority, observer-blinded, randomised, and controlled dose investigation trial. Issue 7 (July 2017) Authors: Rivera, Luis; Pedersen, Rasmus S; Peña, Lourdes; Olsen, Klaus J; Andreasen, Lars V; Kromann, Ingrid; Nielsen, Pernille I; Sørensen, Charlotte; Dietrich, Jes; Bandyopadhyay, Ananda S; Thierry-Carstensen, Birgit Journal: Lancet infectious diseases Issue: Volume 17:Issue 7(2017:Jul.) Page Start: 745 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. First-in-human trial of the post-exposure tuberculosis vaccine H56:IC31 in Mycobacterium tuberculosis infected and non-infected healthy adults. Issue 33 (7th August 2015) Authors: Luabeya, Angelique Kany Kany; Kagina, Benjamin M.N.; Tameris, Michele D.; Geldenhuys, Hennie; Hoff, Soren T.; Shi, Zhongkai; Kromann, Ingrid; Hatherill, Mark; Mahomed, Hassan; Hanekom, Willem A.; Andersen, Peter; Scriba, Thomas J.; Schoeman, Elisma; Krohn, Colleen; Day, Cheryl L.; Africa, Hadn; M... Journal: Vaccine Issue: Volume 33:Issue 33(2015) Page Start: 4130 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. H1:IC31 vaccination is safe and induces long-lived TNF-α+IL-2+CD4 T cell responses in M. tuberculosis infected and uninfected adolescents: A randomized trial. Issue 1 (3rd January 2017) Authors: Rozot, Virginie; Abrahams, Deborah A.; Mauff, Katya; Smit, Erica; Brown, Yolande; Hughes, E. Jane; Makgotlho, Edward; Keyser, Alana; Erasmus, Mzwandile; Makhethe, Lebohang; Africa, Hadn; Hopley, Charles; Steyn, Marcia; Mearns, Helen; Geldenhuys, Hennie D.; Kagina, Benjamin M.; Musvosvi, Munyaradz... Journal: Vaccine Issue: Volume 35:Issue 1(2017) Page Start: 132 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Safety and efficacy of the C-Tb skin test to diagnose Mycobacterium tuberculosis infection, compared with an interferon γ release assay and the tuberculin skin test: a phase 3, double-blind, randomised, controlled trial. Issue 4 (April 2017) Authors: Ruhwald, Morten; Aggerbeck, Henrik; Gallardo, Rafael Vázquez; Hoff, Søren T; Villate, José I; Borregaard, Bettine; Martinez, José A; Kromann, Ingrid; Penas, Antón; Anibarro, Luis L; de Souza-Galvão, Maria Luiza; Sánchez, Francisca; Rodrigo-Pendás, Jose Ángel; Noguera-Julian, Antoni; Martínez-Laca... Journal: Lancet Issue: Volume 5:Issue 4(2017) Page Start: 259 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. The tuberculosis vaccine H4:IC31 is safe and induces a persistent polyfunctional CD4 T cell response in South African adults: A randomized controlled trial. Issue 30 (9th July 2015) Authors: Geldenhuys, Hennie; Mearns, Helen; Miles, David J.C.; Tameris, Michele; Hokey, David; Shi, Zhongkai; Bennett, Sean; Andersen, Peter; Kromann, Ingrid; Hoff, Søren T.; Hanekom, Willem A.; Mahomed, Hassan; Hatherill, Mark; Scriba, Thomas J.; van Rooyen, Michele; Bruce McClain, J.; Ryall, Robert; de ... Journal: Vaccine Issue: Volume 33:Issue 30(2015) Page Start: 3592 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. The tuberculosis vaccine H4:IC31 is safe and induces a persistent polyfunctional CD4 T cell response in South African adults: A randomized controlled trial. Issue 30 (9th July 2015) Authors: Geldenhuys, Hennie; Mearns, Helen; Miles, David J.C.; Tameris, Michele; Hokey, David; Shi, Zhongkai; Bennett, Sean; Andersen, Peter; Kromann, Ingrid; Hoff, Søren T.; Hanekom, Willem A.; Mahomed, Hassan; Hatherill, Mark; Scriba, Thomas J.; van Rooyen, Michele; Bruce McClain, J.; Ryall, Robert; de ... Journal: Vaccine Issue: Volume 33:Issue 30(2015) Page Start: 3592 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. First-in-human trial of the post-exposure tuberculosis vaccine H56:IC31 in Mycobacterium tuberculosis infected and non-infected healthy adults. Issue 33 (7th August 2015) Authors: Luabeya, Angelique Kany Kany; Kagina, Benjamin M.N.; Tameris, Michele D.; Geldenhuys, Hennie; Hoff, Soren T.; Shi, Zhongkai; Kromann, Ingrid; Hatherill, Mark; Mahomed, Hassan; Hanekom, Willem A.; Andersen, Peter; Scriba, Thomas J.; H56-032 Trial Study Group, 1; Schoeman, Elisma; Krohn, Colleen; D... Journal: Vaccine Issue: Volume 33:Issue 33(2015) Page Start: 4130 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗